Dynavax Technologies | Zobowiązania Handlowe



Trade Creditors Zmiana Data
AbbVie 2.94B 2.66B 2024-12
Adma Biologics USD 20.22M 4.2M 2024-12
Amgen USD 1.91B 239M 2024-12
AstraZeneca 22.54B 79M 2025-03
Biogen USD 424.2M 1.5M 2024-12
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 4B 400M 2025-03
Dynavax Technologies USD 9.06M 1.97M 2024-12
Gilead Sciences USD 833M 70M 2024-12
Glaxosmithkline 3.46B 10.01B 2024-12
Merck USD 4.08B 493M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.63B 319M 2024-12
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Roche Holding 4.35B 828M 2024-12
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
TG Therapeutics 41.97M 34.78M 2024-09
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Dynavax Technologies Zobowiązania Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.